Plotted Points Statistics |
1H-1,2,4-TRIAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 19 | 78% | 14% | 78% | 19% |
Total | 19 | 78% | 14% | 78% | 19% |
Sample Statistics |
1H-1,2,4-TRIAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 19 | 86% | Spiked |
Estimated Values | 19 | 86% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 22 | . | |
False Negatives | 3 | 14% | 3 out of 22 |
Not Spiked | 94 | . | |
False Positives | 0 | 0% | 0 out of 94 |
Plotted Points Statistics |
2,4-D |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 95% | 29% | 92% | 32% |
Total | 39 | 95% | 29% | 92% | 32% |
Sample Statistics |
2,4-D |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 93% | Spiked |
Estimated Values | 7 | 17% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 3 | 7% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 42 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 74 |
OBSP Determination: |
2-HYDROXY-4-ISOPROPYLAMINO-6-AMINO-S-TRIAZINE |
METHOD: 2447 , TESTIDCODE: 68659LCM60 |
Plotted Points Statistics |
2-HYDROXY-4-ISOPROPYLAMINO-6-AMINO-S-TRIAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 28 | 85% | 18% | 86% | 18% |
Total | 28 | 85% | 18% | 86% | 18% |
Sample Statistics |
2-HYDROXY-4-ISOPROPYLAMINO-6-AMINO-S-TRIAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 100% | Spiked |
Estimated Values | 15 | 54% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 28 | . | |
False Negatives | 0 | 0% | 0 out of 28 |
Not Spiked | 86 | . | |
False Positives | 3 | 3% | 3 out of 86 |
OBSP Determination: |
2-HYDROXY-4-ISOPROPYLAMINO-6-ETHYLAMINO-S-TRIAZINE (OIET) |
METHOD: 2447 , TESTIDCODE: 68660LCM60 |
Plotted Points Statistics |
2-HYDROXY-4-ISOPROPYLAMINO-6-ETHYLAMINO-S-TRIAZINE (OIET) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 27 | 167% | 81% | 193% | 99% |
Total | 27 | 167% | 81% | 193% | 99% |
Sample Statistics |
2-HYDROXY-4-ISOPROPYLAMINO-6-ETHYLAMINO-S-TRIAZINE (OIET) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 100% | Spiked |
Estimated Values | 20 | 74% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 27 | . | |
False Negatives | 0 | 0% | 0 out of 27 |
Not Spiked | 79 | . | |
False Positives | 2 | 3% | 2 out of 79 |
Plotted Points Statistics |
3-PHENOXYBENZOIC ACID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 28 | 97% | 19% | 102% | 20% |
Total | 28 | 97% | 19% | 102% | 20% |
Sample Statistics |
3-PHENOXYBENZOIC ACID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 93% | Spiked |
Estimated Values | 1 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 30 | . | |
False Negatives | 1 | 3% | 1 out of 30 |
Not Spiked | 86 | . | |
False Positives | 0 | 0% | 0 out of 86 |
Plotted Points Statistics |
4-HYDROXYCHLOROTHALONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 90% | 25% | 94% | 15% |
Total | 32 | 90% | 25% | 94% | 15% |
Sample Statistics |
4-HYDROXYCHLOROTHALONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 94% | Spiked |
Estimated Values | 32 | 94% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 34 | . | |
False Negatives | 2 | 6% | 2 out of 34 |
Not Spiked | 82 | . | |
False Positives | 0 | 0% | 0 out of 80 |
Plotted Points Statistics |
ACEPHATE (ORTHENE) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 87% | 25% | 88% | 18% |
Total | 41 | 87% | 25% | 88% | 18% |
Sample Statistics |
ACEPHATE (ORTHENE) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 98% | Spiked |
Estimated Values | 5 | 12% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 42 | . | |
False Negatives | 1 | 2% | 1 out of 42 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 74 |
Plotted Points Statistics |
ACETOCHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 99% | 39% | 98% | 32% |
Total | 39 | 99% | 39% | 98% | 32% |
Sample Statistics |
ACETOCHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 93% | Spiked |
Estimated Values | 4 | 10% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 3 | 7% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 42 |
Not Spiked | 72 | . | |
False Positives | 0 | 0% | 0 out of 72 |
Plotted Points Statistics |
ACETOCHLOR OXANILIC ACID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 30 | 116% | 29% | 124% | 33% |
Total | 30 | 116% | 29% | 124% | 33% |
Sample Statistics |
ACETOCHLOR OXANILIC ACID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 97% | Spiked |
Estimated Values | 30 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 1 | 3% | 1 out of 31 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Plotted Points Statistics |
ACETOCHLOR SULFONIC ACID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 30 | 98% | 18% | 97% | 21% |
Total | 30 | 98% | 18% | 97% | 21% |
Sample Statistics |
ACETOCHLOR SULFONIC ACID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 97% | Spiked |
Estimated Values | 30 | 97% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 31 | . | |
False Negatives | 0 | 0% | 0 out of 31 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Plotted Points Statistics |
ATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 91% | 28% | 88% | 20% |
Total | 44 | 91% | 28% | 88% | 20% |
Sample Statistics |
ATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 8 | 18% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 72 | . | |
False Positives | 2 | 3% | 2 out of 72 |
Plotted Points Statistics |
AZOXYSTROBIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 43 | 86% | 25% | 81% | 25% |
Total | 43 | 86% | 25% | 81% | 25% |
Sample Statistics |
AZOXYSTROBIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 98% | Spiked |
Estimated Values | 3 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 1 | 2% | 1 out of 44 |
Not Spiked | 72 | . | |
False Positives | 0 | 0% | 0 out of 72 |
Plotted Points Statistics |
BENTAZONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 42 | 90% | 26% | 85% | 20% |
Total | 42 | 90% | 26% | 85% | 20% |
Sample Statistics |
BENTAZONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 42 | 100% | Spiked |
Estimated Values | 9 | 21% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 42 | . | |
False Negatives | 0 | 0% | 0 out of 42 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 72 |
Plotted Points Statistics |
BROMACIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 100% | 17% | 101% | 16% |
Total | 31 | 100% | 17% | 101% | 16% |
Sample Statistics |
BROMACIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 89% | Spiked |
Estimated Values | 3 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 3 | 9% | Spiked |
Spiked | 35 | . | |
False Negatives | 1 | 3% | 1 out of 35 |
Not Spiked | 81 | . | |
False Positives | 0 | 0% | 0 out of 81 |
Plotted Points Statistics |
BROMOXYNIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 80% | 26% | 72% | 15% |
Total | 44 | 80% | 26% | 72% | 15% |
Sample Statistics |
BROMOXYNIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 11 | 25% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 72 | . | |
False Positives | 0 | 0% | 0 out of 72 |
Plotted Points Statistics |
CARBARYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 92% | 33% | 86% | 29% |
Total | 41 | 92% | 33% | 86% | 29% |
Sample Statistics |
CARBARYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 100% | Spiked |
Estimated Values | 4 | 10% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 75 | . | |
False Positives | 1 | 1% | 1 out of 75 |
Plotted Points Statistics |
CARBENDAZIM |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 90% | 11% | 89% | 11% |
Total | 31 | 90% | 11% | 89% | 11% |
Sample Statistics |
CARBENDAZIM |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 97% | Spiked |
Estimated Values | 31 | 97% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 32 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 84 | . | |
False Positives | 0 | 0% | 0 out of 83 |
Plotted Points Statistics |
CHLORIMURON-ETHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 29 | 67% | 29% | 58% | 39% |
Total | 29 | 67% | 29% | 58% | 39% |
Sample Statistics |
CHLORIMURON-ETHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 29 | 91% | Spiked |
Estimated Values | 5 | 16% | Spiked |
Deleted Values | 7 | 7% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 34 | . | |
False Negatives | 3 | 9% | 3 out of 32 |
Not Spiked | 71 | . | |
False Positives | 0 | 0% | 0 out of 66 |
Plotted Points Statistics |
CHLORPYRIFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 38 | 89% | 28% | 87% | 26% |
Total | 38 | 89% | 28% | 87% | 26% |
Sample Statistics |
CHLORPYRIFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 90% | Spiked |
Estimated Values | 2 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 5% | Spiked |
Spiked | 42 | . | |
False Negatives | 2 | 5% | 2 out of 42 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 74 |
Plotted Points Statistics |
CIS-CYHALOTHRIC ACID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 4 | 80% | 17% | 74% | 18% |
Total | 4 | 80% | 17% | 74% | 18% |
Sample Statistics |
CIS-CYHALOTHRIC ACID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 4 | 44% | Spiked |
Estimated Values | 1 | 11% | Spiked |
Deleted Values | 10 | 9% | Spiked + Not Spiked |
Spiked, Censored | 2 | 22% | Spiked |
Spiked | 10 | . | |
False Negatives | 3 | 33% | 3 out of 9 |
Not Spiked | 106 | . | |
False Positives | 0 | 0% | 0 out of 97 |
Plotted Points Statistics |
CIS-PERMETHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 54% | 20% | 53% | 17% |
Total | 34 | 54% | 20% | 53% | 17% |
Sample Statistics |
CIS-PERMETHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 89% | Spiked |
Estimated Values | 7 | 18% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 5% | Spiked |
Spiked | 38 | . | |
False Negatives | 2 | 5% | 2 out of 38 |
Not Spiked | 78 | . | |
False Positives | 0 | 0% | 0 out of 78 |
Plotted Points Statistics |
DECHLOROMETOLACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 20 | 86% | 16% | 87% | 13% |
Total | 20 | 86% | 16% | 87% | 13% |
Sample Statistics |
DECHLOROMETOLACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 20 | 91% | Spiked |
Estimated Values | 1 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 22 | . | |
False Negatives | 2 | 9% | 2 out of 22 |
Not Spiked | 94 | . | |
False Positives | 0 | 0% | 0 out of 94 |
Plotted Points Statistics |
DEETHYLATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 33 | 80% | 25% | 79% | 16% |
Total | 33 | 80% | 25% | 79% | 16% |
Sample Statistics |
DEETHYLATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 97% | Spiked |
Estimated Values | 8 | 24% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 34 | . | |
False Negatives | 1 | 3% | 1 out of 34 |
Not Spiked | 82 | . | |
False Positives | 1 | 1% | 1 out of 82 |
Plotted Points Statistics |
DEETHYLDEISOPROPYLATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 29 | 92% | 71% | 76% | 22% |
Total | 29 | 92% | 71% | 76% | 22% |
Sample Statistics |
DEETHYLDEISOPROPYLATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 29 | 85% | Spiked |
Estimated Values | 17 | 50% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 34 | . | |
False Negatives | 4 | 12% | 4 out of 34 |
Not Spiked | 82 | . | |
False Positives | 0 | 0% | 0 out of 82 |
Plotted Points Statistics |
DEISOPROPYLATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 88% | 29% | 92% | 20% |
Total | 32 | 88% | 29% | 92% | 20% |
Sample Statistics |
DEISOPROPYLATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 97% | Spiked |
Estimated Values | 5 | 15% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 1 | 3% | 1 out of 33 |
Not Spiked | 83 | . | |
False Positives | 1 | 1% | 1 out of 83 |
Plotted Points Statistics |
DESULFINYLFIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 155% | 233% | 100% | 14% |
Total | 32 | 155% | 233% | 100% | 14% |
Sample Statistics |
DESULFINYLFIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 84 | . | |
False Positives | 2 | 2% | 2 out of 84 |
Plotted Points Statistics |
DIAZINON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 87% | 38% | 87% | 38% |
Total | 41 | 87% | 38% | 87% | 38% |
Sample Statistics |
DIAZINON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 100% | Spiked |
Estimated Values | 3 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 72 | . | |
False Positives | 3 | 4% | 3 out of 72 |
Plotted Points Statistics |
DICAMBA |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 25 | 103% | 15% | 101% | 11% |
Total | 25 | 103% | 15% | 101% | 11% |
Sample Statistics |
DICAMBA |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 25 | 100% | Spiked |
Estimated Values | 25 | 100% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 25 | . | |
False Negatives | 0 | 0% | 0 out of 25 |
Not Spiked | 91 | . | |
False Positives | 0 | 0% | 0 out of 91 |
Plotted Points Statistics |
DICHLOROVOS (DICHLORVOS) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 67% | 19% | 65% | 18% |
Total | 44 | 67% | 19% | 65% | 18% |
Sample Statistics |
DICHLOROVOS (DICHLORVOS) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 7 | 16% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 69 | . | |
False Positives | 0 | 0% | 0 out of 69 |
Plotted Points Statistics |
DICROTOPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 114% | 144% | 89% | 15% |
Total | 41 | 114% | 144% | 89% | 15% |
Sample Statistics |
DICROTOPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 93% | Spiked |
Estimated Values | 10 | 23% | Spiked |
Deleted Values | 4 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 3 | 7% | 3 out of 44 |
Not Spiked | 71 | . | |
False Positives | 1 | 1% | 1 out of 68 |
Plotted Points Statistics |
DIFLUBENZURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 92% | 18% | 91% | 14% |
Total | 31 | 92% | 18% | 91% | 14% |
Sample Statistics |
DIFLUBENZURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 97% | Spiked |
Estimated Values | 3 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 1 | 3% | 1 out of 32 |
Not Spiked | 84 | . | |
False Positives | 0 | 0% | 0 out of 84 |
Plotted Points Statistics |
DIKETONITRILE-ISOXAFLUTOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 28 | 99% | 14% | 100% | 16% |
Total | 28 | 99% | 14% | 100% | 16% |
Sample Statistics |
DIKETONITRILE-ISOXAFLUTOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 97% | Spiked |
Estimated Values | 7 | 24% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 29 | . | |
False Negatives | 1 | 3% | 1 out of 29 |
Not Spiked | 77 | . | |
False Positives | 1 | 1% | 1 out of 77 |
Plotted Points Statistics |
DIMETHENAMID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 99% | 19% | 95% | 19% |
Total | 34 | 99% | 19% | 95% | 19% |
Sample Statistics |
DIMETHENAMID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 97% | Spiked |
Estimated Values | 4 | 11% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 81 | . | |
False Positives | 0 | 0% | 0 out of 81 |
Plotted Points Statistics |
DIMETHOATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 88% | 27% | 88% | 21% |
Total | 44 | 88% | 27% | 88% | 21% |
Sample Statistics |
DIMETHOATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 1 | 2% | 1 out of 45 |
Not Spiked | 71 | . | |
False Positives | 0 | 0% | 0 out of 71 |
Plotted Points Statistics |
DIURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 26 | 103% | 33% | 100% | 15% |
Total | 26 | 103% | 33% | 100% | 15% |
Sample Statistics |
DIURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 26 | 84% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 3 | 10% | Spiked |
Spiked | 31 | . | |
False Negatives | 2 | 6% | 2 out of 31 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Plotted Points Statistics |
ETHOPROPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 95% | 26% | 94% | 24% |
Total | 44 | 95% | 26% | 94% | 24% |
Sample Statistics |
ETHOPROPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 1 | 2% | 1 out of 45 |
Not Spiked | 69 | . | |
False Positives | 3 | 4% | 3 out of 69 |
Plotted Points Statistics |
ETOXAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 70% | 13% | 70% | 12% |
Total | 34 | 70% | 13% | 70% | 12% |
Sample Statistics |
ETOXAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 100% | Spiked |
Estimated Values | 1 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 34 | . | |
False Negatives | 0 | 0% | 0 out of 34 |
Not Spiked | 82 | . | |
False Positives | 0 | 0% | 0 out of 82 |
Plotted Points Statistics |
FIPRONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 79% | 22% | 75% | 12% |
Total | 44 | 79% | 22% | 75% | 12% |
Sample Statistics |
FIPRONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 66 | . | |
False Positives | 2 | 3% | 2 out of 66 |
Plotted Points Statistics |
FIPRONIL AMIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 17 | 104% | 21% | 105% | 21% |
Total | 17 | 104% | 21% | 105% | 21% |
Sample Statistics |
FIPRONIL AMIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 17 | 81% | Spiked |
Estimated Values | 1 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 21 | . | |
False Negatives | 4 | 19% | 4 out of 21 |
Not Spiked | 95 | . | |
False Positives | 0 | 0% | 0 out of 95 |
Plotted Points Statistics |
FIPRONIL SULFIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 36 | 89% | 13% | 90% | 15% |
Total | 36 | 89% | 13% | 90% | 15% |
Sample Statistics |
FIPRONIL SULFIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 100% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 36 | . | |
False Negatives | 0 | 0% | 0 out of 36 |
Not Spiked | 80 | . | |
False Positives | 2 | 3% | 2 out of 80 |
Plotted Points Statistics |
FIPRONIL SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 25 | 85% | 13% | 87% | 10% |
Total | 25 | 85% | 13% | 87% | 10% |
Sample Statistics |
FIPRONIL SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 25 | 100% | Spiked |
Estimated Values | 3 | 12% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 25 | . | |
False Negatives | 0 | 0% | 0 out of 25 |
Not Spiked | 83 | . | |
False Positives | 5 | 6% | 5 out of 83 |
Plotted Points Statistics |
FLUOMETURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 29 | 110% | 34% | 108% | 25% |
Total | 29 | 110% | 34% | 108% | 25% |
Sample Statistics |
FLUOMETURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 29 | 94% | Spiked |
Estimated Values | 4 | 13% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 6% | Spiked |
Spiked | 31 | . | |
False Negatives | 0 | 0% | 0 out of 31 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Plotted Points Statistics |
HALOSULFURON-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 82% | 27% | 86% | 27% |
Total | 35 | 82% | 27% | 86% | 27% |
Sample Statistics |
HALOSULFURON-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 83% | Spiked |
Estimated Values | 7 | 17% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 42 | . | |
False Negatives | 6 | 14% | 6 out of 42 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 74 |
Plotted Points Statistics |
HEXAZINONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 99% | 16% | 104% | 16% |
Total | 32 | 99% | 16% | 104% | 16% |
Sample Statistics |
HEXAZINONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 4 | 13% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 84 | . | |
False Positives | 1 | 1% | 1 out of 84 |
Plotted Points Statistics |
HYDROXYMETOLACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 21 | 110% | 24% | 114% | 17% |
Total | 21 | 110% | 24% | 114% | 17% |
Sample Statistics |
HYDROXYMETOLACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 21 | 95% | Spiked |
Estimated Values | 2 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 22 | . | |
False Negatives | 1 | 5% | 1 out of 22 |
Not Spiked | 94 | . | |
False Positives | 0 | 0% | 0 out of 94 |
Plotted Points Statistics |
HYDROXYSIMAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 23 | 81% | 29% | 87% | 21% |
Total | 23 | 81% | 29% | 87% | 21% |
Sample Statistics |
HYDROXYSIMAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 23 | 92% | Spiked |
Estimated Values | 23 | 92% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 25 | . | |
False Negatives | 2 | 8% | 2 out of 25 |
Not Spiked | 84 | . | |
False Positives | 2 | 2% | 2 out of 83 |
Plotted Points Statistics |
IMAZETHAPYR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 30 | 95% | 20% | 91% | 23% |
Total | 30 | 95% | 20% | 91% | 23% |
Sample Statistics |
IMAZETHAPYR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 94% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 2 | 6% | 2 out of 32 |
Not Spiked | 84 | . | |
False Positives | 0 | 0% | 0 out of 84 |
Plotted Points Statistics |
IMIDACLOPRID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 93% | 17% | 91% | 16% |
Total | 34 | 93% | 17% | 91% | 16% |
Sample Statistics |
IMIDACLOPRID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 100% | Spiked |
Estimated Values | 3 | 9% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 34 |
Not Spiked | 81 | . | |
False Positives | 0 | 0% | 0 out of 81 |
Plotted Points Statistics |
LINURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 94% | 20% | 93% | 23% |
Total | 34 | 94% | 20% | 93% | 23% |
Sample Statistics |
LINURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 100% | Spiked |
Estimated Values | 1 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 34 | . | |
False Negatives | 0 | 0% | 0 out of 34 |
Not Spiked | 82 | . | |
False Positives | 1 | 1% | 1 out of 82 |
Plotted Points Statistics |
MALATHION |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 92% | 35% | 86% | 34% |
Total | 40 | 92% | 35% | 86% | 34% |
Sample Statistics |
MALATHION |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 98% | Spiked |
Estimated Values | 5 | 12% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 74 |
Plotted Points Statistics |
METALAXYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 94% | 16% | 96% | 17% |
Total | 31 | 94% | 16% | 96% | 17% |
Sample Statistics |
METALAXYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 100% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 0 | 0% | 0 out of 31 |
Not Spiked | 85 | . | |
False Positives | 5 | 6% | 5 out of 85 |
Plotted Points Statistics |
METCONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 89% | 14% | 87% | 16% |
Total | 34 | 89% | 14% | 87% | 16% |
Sample Statistics |
METCONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 97% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 1 | 3% | 1 out of 35 |
Not Spiked | 81 | . | |
False Positives | 0 | 0% | 0 out of 81 |
Plotted Points Statistics |
METHAMIDOPHOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 36 | 108% | 22% | 109% | 21% |
Total | 36 | 108% | 22% | 109% | 21% |
Sample Statistics |
METHAMIDOPHOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 100% | Spiked |
Estimated Values | 5 | 14% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 36 | . | |
False Negatives | 0 | 0% | 0 out of 36 |
Not Spiked | 80 | . | |
False Positives | 0 | 0% | 0 out of 80 |
Plotted Points Statistics |
METHOMYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 96% | 40% | 87% | 32% |
Total | 39 | 96% | 40% | 87% | 32% |
Sample Statistics |
METHOMYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 93% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 42 | . | |
False Negatives | 2 | 5% | 2 out of 42 |
Not Spiked | 69 | . | |
False Positives | 1 | 1% | 1 out of 69 |
Plotted Points Statistics |
METHOXYFENOZIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 30 | 98% | 16% | 101% | 20% |
Total | 30 | 98% | 16% | 101% | 20% |
Sample Statistics |
METHOXYFENOZIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 97% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 1 | 3% | 1 out of 31 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Plotted Points Statistics |
METOLACHLOR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 96% | 14% | 98% | 12% |
Total | 34 | 96% | 14% | 98% | 12% |
Sample Statistics |
METOLACHLOR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 97% | Spiked |
Estimated Values | 3 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 1 | 3% | 1 out of 35 |
Not Spiked | 79 | . | |
False Positives | 0 | 0% | 0 out of 79 |
Plotted Points Statistics |
METOLACHLOR OXANILIC ACID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 27 | 109% | 23% | 112% | 23% |
Total | 27 | 109% | 23% | 112% | 23% |
Sample Statistics |
METOLACHLOR OXANILIC ACID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 87% | Spiked |
Estimated Values | 27 | 87% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 6% | Spiked |
Spiked | 31 | . | |
False Negatives | 2 | 6% | 2 out of 31 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Plotted Points Statistics |
METOLACHLOR SULFONIC ACID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 24 | 87% | 25% | 78% | 27% |
Total | 24 | 87% | 25% | 78% | 27% |
Sample Statistics |
METOLACHLOR SULFONIC ACID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 24 | 92% | Spiked |
Estimated Values | 7 | 27% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 26 | . | |
False Negatives | 2 | 8% | 2 out of 26 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 90 |
Plotted Points Statistics |
METRIBUZIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 30 | 101% | 20% | 102% | 18% |
Total | 30 | 101% | 20% | 102% | 18% |
Sample Statistics |
METRIBUZIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 97% | Spiked |
Estimated Values | 1 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 1 | 3% | 1 out of 31 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Plotted Points Statistics |
MYCLOBUTANIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 33 | 90% | 16% | 88% | 14% |
Total | 33 | 90% | 16% | 88% | 14% |
Sample Statistics |
MYCLOBUTANIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 97% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 34 | . | |
False Negatives | 0 | 0% | 0 out of 34 |
Not Spiked | 82 | . | |
False Positives | 0 | 0% | 0 out of 82 |
Plotted Points Statistics |
N-(3,4-DICHLOROPHENYL)-N'-METHYLUREA |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 38 | 109% | 35% | 101% | 24% |
Total | 38 | 109% | 35% | 101% | 24% |
Sample Statistics |
N-(3,4-DICHLOROPHENYL)-N'-METHYLUREA |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 93% | Spiked |
Estimated Values | 8 | 20% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 3 | 7% | 3 out of 41 |
Not Spiked | 75 | . | |
False Positives | 0 | 0% | 0 out of 75 |
Plotted Points Statistics |
ORYZALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 29 | 107% | 20% | 102% | 18% |
Total | 29 | 107% | 20% | 102% | 18% |
Sample Statistics |
ORYZALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 29 | 91% | Spiked |
Estimated Values | 10 | 31% | Spiked |
Deleted Values | 3 | 3% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 32 | . | |
False Negatives | 2 | 6% | 2 out of 32 |
Not Spiked | 84 | . | |
False Positives | 0 | 0% | 0 out of 81 |
Plotted Points Statistics |
PIPERONYL BUTOXIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 83% | 23% | 83% | 16% |
Total | 45 | 83% | 23% | 83% | 16% |
Sample Statistics |
PIPERONYL BUTOXIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 100% | Spiked |
Estimated Values | 2 | 4% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 45 |
Not Spiked | 71 | . | |
False Positives | 0 | 0% | 0 out of 71 |
Plotted Points Statistics |
PROMETON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 94% | 15% | 95% | 15% |
Total | 35 | 94% | 15% | 95% | 15% |
Sample Statistics |
PROMETON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 1 | 3% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 81 | . | |
False Positives | 0 | 0% | 0 out of 80 |
Plotted Points Statistics |
PROPAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 33 | 101% | 20% | 101% | 17% |
Total | 33 | 101% | 20% | 101% | 17% |
Sample Statistics |
PROPAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 97% | Spiked |
Estimated Values | 1 | 3% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 34 | . | |
False Negatives | 1 | 3% | 1 out of 34 |
Not Spiked | 82 | . | |
False Positives | 2 | 2% | 2 out of 82 |
Plotted Points Statistics |
PROPICONAZOLE (TILT) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 24 | 93% | 19% | 92% | 16% |
Total | 24 | 93% | 19% | 92% | 16% |
Sample Statistics |
PROPICONAZOLE (TILT) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 24 | 89% | Spiked |
Estimated Values | 1 | 4% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 4% | Spiked |
Spiked | 27 | . | |
False Negatives | 2 | 7% | 2 out of 27 |
Not Spiked | 83 | . | |
False Positives | 0 | 0% | 0 out of 83 |
Plotted Points Statistics |
PROPOXUR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 44 | 102% | 31% | 100% | 28% |
Total | 44 | 102% | 31% | 100% | 28% |
Sample Statistics |
PROPOXUR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 44 | 100% | Spiked |
Estimated Values | 4 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 44 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 72 | . | |
False Positives | 0 | 0% | 0 out of 72 |
Plotted Points Statistics |
PYRACLOSTROBIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 85% | 16% | 81% | 22% |
Total | 31 | 85% | 16% | 81% | 22% |
Sample Statistics |
PYRACLOSTROBIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 97% | Spiked |
Estimated Values | 4 | 13% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 1 | 3% | 1 out of 32 |
Not Spiked | 84 | . | |
False Positives | 0 | 0% | 0 out of 84 |
Plotted Points Statistics |
SIMAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 92% | 28% | 89% | 22% |
Total | 35 | 92% | 28% | 89% | 22% |
Sample Statistics |
SIMAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 3 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 78 | . | |
False Positives | 1 | 1% | 1 out of 78 |
Plotted Points Statistics |
SULFENTRAZONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 32 | 99% | 17% | 100% | 17% |
Total | 32 | 99% | 17% | 100% | 17% |
Sample Statistics |
SULFENTRAZONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 32 | 100% | Spiked |
Estimated Values | 5 | 16% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 0 | 0% | 0 out of 32 |
Not Spiked | 84 | . | |
False Positives | 0 | 0% | 0 out of 84 |
Plotted Points Statistics |
SULFOMETURON-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 42 | 85% | 25% | 88% | 17% |
Total | 42 | 85% | 25% | 88% | 17% |
Sample Statistics |
SULFOMETURON-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 42 | 93% | Spiked |
Estimated Values | 6 | 13% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 4% | Spiked |
Spiked | 45 | . | |
False Negatives | 1 | 2% | 1 out of 45 |
Not Spiked | 71 | . | |
False Positives | 0 | 0% | 0 out of 71 |
Plotted Points Statistics |
TEBUCONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 86% | 12% | 83% | 9% |
Total | 35 | 86% | 12% | 83% | 9% |
Sample Statistics |
TEBUCONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 3 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 81 | . | |
False Positives | 0 | 0% | 0 out of 81 |
Plotted Points Statistics |
TEBUPIRIMPHOS (PHOSTEBUPIRIM) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 83% | 26% | 79% | 20% |
Total | 40 | 83% | 26% | 79% | 20% |
Sample Statistics |
TEBUPIRIMPHOS (PHOSTEBUPIRIM) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 98% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 75 | . | |
False Positives | 0 | 0% | 0 out of 75 |
Plotted Points Statistics |
TEBUTHIURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 94% | 13% | 96% | 12% |
Total | 35 | 94% | 13% | 96% | 12% |
Sample Statistics |
TEBUTHIURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 81 | . | |
False Positives | 0 | 0% | 0 out of 81 |
Plotted Points Statistics |
TERBUFOS |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 37 | 65% | 18% | 62% | 16% |
Total | 37 | 65% | 18% | 62% | 16% |
Sample Statistics |
TERBUFOS |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 37 | 97% | Spiked |
Estimated Values | 4 | 11% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 38 | . | |
False Negatives | 1 | 3% | 1 out of 38 |
Not Spiked | 78 | . | |
False Positives | 1 | 1% | 1 out of 78 |
Plotted Points Statistics |
TERBUFOS SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 165% | 99% | 165% | 103% |
>= Reporting Level | 25 | 105% | 26% | 99% | 23% |
Total | 27 | 110% | 35% | 99% | 29% |
Sample Statistics |
TERBUFOS SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 96% | Spiked |
Estimated Values | 7 | 25% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 29 | . | |
False Negatives | 1 | 4% | 1 out of 28 |
Not Spiked | 87 | . | |
False Positives | 1 | 1% | 1 out of 86 |
Plotted Points Statistics |
TERBUFOS SULFOXIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 33 | 86% | 24% | 85% | 29% |
Total | 33 | 86% | 24% | 85% | 29% |
Sample Statistics |
TERBUFOS SULFOXIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 100% | Spiked |
Estimated Values | 10 | 30% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 33 | . | |
False Negatives | 0 | 0% | 0 out of 33 |
Not Spiked | 74 | . | |
False Positives | 12 | 16% | 12 out of 74 |
Plotted Points Statistics |
TETRACONAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 92% | 20% | 93% | 17% |
Total | 31 | 92% | 20% | 93% | 17% |
Sample Statistics |
TETRACONAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 100% | Spiked |
Estimated Values | 4 | 13% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 0 | 0% | 0 out of 31 |
Not Spiked | 85 | . | |
False Positives | 0 | 0% | 0 out of 85 |
Plotted Points Statistics |
THIOBENCARB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 41 | 91% | 26% | 93% | 23% |
Total | 41 | 91% | 26% | 93% | 23% |
Sample Statistics |
THIOBENCARB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 100% | Spiked |
Estimated Values | 2 | 5% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 41 | . | |
False Negatives | 0 | 0% | 0 out of 41 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 74 |
Plotted Points Statistics |
TRANS-PERMETHRIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 34 | 61% | 25% | 60% | 20% |
Total | 34 | 61% | 25% | 60% | 20% |
Sample Statistics |
TRANS-PERMETHRIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 89% | Spiked |
Estimated Values | 7 | 18% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 5% | Spiked |
Spiked | 38 | . | |
False Negatives | 2 | 5% | 2 out of 38 |
Not Spiked | 78 | . | |
False Positives | 0 | 0% | 0 out of 78 |
Plotted Points Statistics |
TRICLOPYR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 33 | 103% | 19% | 105% | 20% |
Total | 33 | 103% | 19% | 105% | 20% |
Sample Statistics |
TRICLOPYR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 94% | Spiked |
Estimated Values | 15 | 43% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 35 | . | |
False Negatives | 1 | 3% | 1 out of 35 |
Not Spiked | 81 | . | |
False Positives | 0 | 0% | 0 out of 81 |